Volume 39, Issue 2 , Pages 124-129, February 2012
An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis
Abstract
In a project to characterise new antibacterial chemotypes from plants, hyperenone A and hypercalin B were isolated from the hexane and chloroform extracts of the aerial parts of Hypericum acmosepalum. The structures of both compounds were characterised by extensive one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy and were confirmed by mass spectrometry. Hyperenone A and hypercalin B exhibited antibacterial activity against multidrug-resistant strains of Staphylococcus aureus, with minimum inhibition concentration ranges of 2–128
mg/L and 0.5–128
mg/L, respectively. Hyperenone A also showed growth-inhibitory activity against Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG at 75
mg/L and 100
mg/L. Neither hyperenone A nor hypercalin B inhibited the growth of Escherichia coli and both were non-toxic to cultured mammalian macrophage cells. Both compounds were tested for their ability to inhibit the ATP-dependent MurE ligase of M. tuberculosis, a crucial enzyme in the cytoplasmic steps of peptidoglycan biosynthesis. Hyperenone A inhibited MurE selectively, whereas hypercalin B did not have any effect on enzyme activity.
Keywords: Hypericum acmosepalum, Hyperenone A, Hypercalin B, Staphylococcus aureus, Tuberculosis, Peptidoglycan, MurE ligase
To access this article, please choose from the options below
PII: S0924-8579(11)00402-X
doi:10.1016/j.ijantimicag.2011.09.018
© 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Volume 39, Issue 2 , Pages 124-129, February 2012
